OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat ovarian and endometrial cancers
Disease control Recruiting nowThis early-phase study tests a combination of two experimental drugs (M1774 and ZEN-3694) in people whose ovarian or endometrial cancer has returned after previous treatment. The goal is to find the safest dose and see how well the drugs work together to stop cancer cell growth. …
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:26 UTC
-
Shorter maintenance therapy may be just as effective for ovarian cancer
Disease control Recruiting nowThis study tests whether taking the drug olaparib for one year works as well as taking it for two years to keep ovarian cancer from coming back. Participants have a specific genetic type of advanced ovarian cancer (BRCA mutation or HRD positive) and have already responded to init…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 03:26 UTC
-
Could a pneumonia drug outsmart resistant ovarian cancer?
Disease control Recruiting nowThis study tests whether atovaquone, a drug normally used for infections, can help people with a type of ovarian cancer that no longer responds to standard platinum chemotherapy. About 28 adults with this resistant cancer will take atovaquone to see if it slows tumor growth. The …
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 05, 2026 11:54 UTC